ProgestinsEstrogen Replacement TherapyEstrogens, Conjugated (USP)Medroxyprogesterone AcetateEstrogensHormone Replacement TherapyPostmenopauseMenopauseWomen's HealthMastodyniaBreast NeoplasmsPrepaid Health PlansEndometrial NeoplasmsIncidenceRisk FactorsHysterectomyProportional Hazards ModelsUnited StatesRiskProgesterone CongenersMedroxyprogesteroneReceptors, EstrogenGallbladder DiseasesFollow-Up StudiesDrug Therapy, CombinationEstradiolCarcinoma, LobularEstrogen Receptor alphaDouble-Blind MethodAdministration, CutaneousDrug CombinationsProgesteroneMammographyCohort StudiesRandomized Controlled Trials as TopicHot FlashesCarcinoma, Ductal, BreastEstrogen Receptor betaHormonesOvariectomyCase-Control StudiesCholecystectomyCaliforniaAge FactorsReceptors, ProgesteroneContraceptives, OralNorethindroneProspective StudiesPromegestoneOdds RatioQuestionnairesFranceNorpregnenesFollicle Stimulating HormoneGonadal Steroid HormonesThyroid HormonesLuteinizing HormoneObservationAntineoplastic Agents, HormonalHuman Growth HormoneGonadotropin-Releasing HormoneEstradiol CongenersSelective Estrogen Receptor ModulatorsNorgestrelTamoxifenNorpregnadienesEthinyl EstradiolRisk AssessmentDrug Administration ScheduleParathyroid HormoneNeoplasms, Hormone-DependentNorprogesteronesTestosteroneLevonorgestrelDydrogesteronePost and Core TechniqueAndrogen AntagonistsEstrogens, Catechol